These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10897789)

  • 21. [Possibilities of drug treatment in inflammatory intestinal diseases].
    van Hogezand RA; Lamers CB
    Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2536-40. PubMed ID: 7830801
    [No Abstract]   [Full Text] [Related]  

  • 22. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.
    Frøslie KF; Jahnsen J; Moum BA; Vatn MH;
    Gastroenterology; 2007 Aug; 133(2):412-22. PubMed ID: 17681162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The treatment of inflammatory bowel disease in children.
    Wyllie R; Sarigol S
    Clin Pediatr (Phila); 1998 Jul; 37(7):421-5. PubMed ID: 9675435
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current medical treatment of inflammatory bowel disease].
    Bosques-Padilla F
    Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():92-101. PubMed ID: 18277494
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy of chronic inflammatory bowel diseases].
    Peskar BM
    Verh Dtsch Ges Inn Med; 1990; 96():706-12. PubMed ID: 2092510
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cyclosporine A and chronic inflammatory diseases of the digestive tract].
    Brazier F; Finet L; Duchmann JC; Dupas JL
    Gastroenterol Clin Biol; 1995 May; 19(5):494-504. PubMed ID: 7590001
    [No Abstract]   [Full Text] [Related]  

  • 29. Pregnancy and inflammatory bowel disease.
    Mahadevan U
    Gastroenterol Clin North Am; 2009 Dec; 38(4):629-49. PubMed ID: 19913206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical therapy of specific clinical presentations.
    Michetti P; Peppercorn MA
    Gastroenterol Clin North Am; 1999 Jun; 28(2):353-70, viii. PubMed ID: 10372272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical treatment of ulcerative colitis. Some reflections.
    Banks C; Forbes A
    Dig Liver Dis; 2007 Apr; 39(4):338-41. PubMed ID: 17317345
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inflammatory bowel diseases].
    Kruis W
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S73-5. PubMed ID: 15368174
    [No Abstract]   [Full Text] [Related]  

  • 34. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
    Domènech E; Hinojosa J; Esteve-Comas M; Gomollón F; Herrera JM; Bastida G; Obrador A; Ruiz R; Saro C; Gassull MA;
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1347-52. PubMed ID: 15606397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advances in the topical steroid treatment of inflammatory bowel diseases].
    Díaz Blasco J; Robledo Andrés P
    Rev Esp Enferm Dig; 1995 Nov; 87(11):802-7. PubMed ID: 8534536
    [No Abstract]   [Full Text] [Related]  

  • 36. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease.
    Goldenberg BA; Rawsthorne P; Bernstein CN
    Am J Gastroenterol; 2004 Sep; 99(9):1744-8. PubMed ID: 15330913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [What is new in the standard therapy of inflammatory bowel diseases?].
    Schölmerich J
    Internist (Berl); 1999 Dec; 40(12):1288-99. PubMed ID: 10642916
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug treatment of chronic inflammatory diseases of the intestine].
    Modigliani R
    Schweiz Med Wochenschr; 1988 May; 118(20):737. PubMed ID: 2898809
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
    Prantera C; Scribano ML
    Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.